Weekly fractionated high dose palliative radiotherapy in advanced breast cancer
Phase 1
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2021/09/036217
- Lead Sponsor
- All India Institute of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Histopathologically proven primary breast cancer deemed surgically inoperable
2)Clinically or radiologically T4 disease staged based on 8th Ed TNM staging system,
3)Age >18years,
4)Eastern co-operative oncology group performance score of <=3.
Exclusion Criteria
1) male breast cancer
2) history of second malignancy
3) prior breast or thoracic irradiation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute radiation toxicityTimepoint: every week during radiotherapy, and 1 month after radiotherapy
- Secondary Outcome Measures
Name Time Method ocal control rate, Local progression free survival, Overall survivalTimepoint: every 3 monthly upto 2 years